Invivyd (IVVD) SC 13D Adagio Therapeutics / Population Health Equity Partners III ownership change

Exhibit 1

JOINT FILING AGREEMENT

The undersigned hereby agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. The undersigned acknowledge that each is responsible for the timely filing of such statement on Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning him, her or it contained therein, but shall not be responsible for the completeness or accuracy of the information concerning the others of the undersigned, except to the extent that it knows or has reason to believe that such information is inaccurate or incomplete. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

Dated: April 6, 2022

Population Health Equity Partners III, L.P.
By:	Population Health Equity Partners III GP, LLC
Its:	General Partner
By:	/s/  Christopher Cox
	Christopher Cox, Managing Member

Population Health Equity Partners III GP, LLC
By:	/s/  Christopher Cox
	Christopher Cox, Managing Member

Population Health Equity Partners VII, L.P.
By:	Population Health Equity Partners VII GP, LLC
Its:	General Partner
By:	/s/  Christopher Cox
	Christopher Cox, Managing Member

Population Healthy Equity Partners VII GP, LLC
By:	/s/  Christopher Cox
	Christopher Cox, Managing Member
/s/ Clive Meanwell
Clive Meanwell
/s/ Christopher Cox
Christopher Cox